On this page Agenda Applications for consideration at this meeting 1643 Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer Disease 1649 Modification of the wording of minimally invasive glaucoma surgery (MIGS) existing item number to encompass the use of a microcatheter 1651 Integrated, closed-system, extracorporeal photopheresis systems for the treatment of chronic graft-versus-host disease Related information Committee: PICO Advisory Subcommittee (PASC)